Log in

  • November 20, 2007 2:23 PM | Brad Miller (Administrator)

    Wow! This year has gone by fast. Thank you for allowing me to serve as your president. It has been an honor. I would also like to thank the current board for sharing all of their time and talents with WMSHP. It has been a pleasure working with all of them. I would especially like to recognize the outgoing members, Jesse Hogue, Ted Riley, and Shaun Phillips, for their dedication over the last several years. Finally, congratulations to the newly elected board members:

    Cherie Woodhams

    Kim Melgarejo

    Technician Member
    Bill Kriel
      Board Members
    Michelle Brodin
    Adam Drzewicki
    Renee Marana
    Sarah Paulson

    I have one last order of business to share with you before I turn the reigns over to Dana Staat, your incoming president. The MPA has just called for WMSHP to select three delegates to send to the 2008 MPA House of Delegates. The Session of the House will be held on Saturday, March 1st, from 1:00 - 4:00 P.M. at the Dearborn Hyatt Regency. If you are an active MPA member and are interested in representing WMSHP as a delegate or would like to obtain more information, please contact me via e-mail at ryanbickel@borgess.com by Monday, December 31, 2007. The Session of the House is held during the MPA Annual Convention & Exposition (ACE), but participation in the ACE is not mandatory. Delegates, who choose to only participate in the Session of the House, will have their registration fee waived for that event.

    Finally, if anyone would like to offer a resolution to the House of Delegates, please notify myself or another WMSHP board member by the January 10th meeting. This will give us adequate time to discuss it and file it with the Secretary of the House for consideration.

  • October 25, 2007 2:24 PM | Brad Miller (Administrator)

    To vote, WMSHP members should fill out the ballot which has been mailed to them. Return the completed ballot via U.S. Mail (postmarked by Nov. 2nd), give it to any Board member, or take it to the November meeting.


    Cherie Woodhams is a 1991 graduate of Ferris State University with a Bachelors of Pharmacy degree. She has experience as a staff and clinical pharmacist on Cardiology, Pediatrics, and the Neonatal ICU. In her current position as Pharmacy Educator, she is involved in training and orientation of pharmacists and pharmacy technicians. She is also presently on the Advisory Board of Everest Career Training Institute.


    Kim Melgarejo is currently a Pharmacy Manager at Borgess Medical Center and Borgess Pipp Hospital. She graduated from West Virginia University with her pharmacy degree and then pursued a pharmacy practice residency at Riverside Methodist Hospital. Soon after her residency she moved to Michigan and has worked at BMC as a clinical pharmacy specialist, clinical pharmacy manager, and now a pharmacy manager. She has been a board member of WMSHP since 2005.


    Michelle Brodin graduated in 2003 with a Doctorate in Pharmacy from South Dakota State University. She completed a pharmacy practice residency at Mercy General Health Partners in Muskegon in 2004. Dr. Brodin is currently serving as the Pharmacy Education Coordinator and Residency Program Director at MGHP. She has a passion for clinical pharmacy and has presented numerous at ASHP Midyear Clinical Meetings focusing on clinical advancement of the profession of pharmacy.

    Melanie Crain graduated from Ferris State University College of Pharmacy in 2006. She completed her Pharmacy Practice Residency at Saint Mary's Health Care in August 2007, and currently works at Metro Health Hospital as a Clinical Pharmacy Specialist.

    Adam Drzewicki graduated with his Pharm.D. from the University of Michigan in 2000. After graduation, he completed a Pharmacy Practice Residency at Parkview Hospital in Fort Wayne, Indiana. He then accepted a clinical pharmacist position in cardiology at Borgess Medical Center in Kalamazoo. Today his position is as a clinical pharmacist in both cardiology and pharmacy system applications.

    Andrea Goodrich is a clinical pharmacist at St. Mary's Health Care in Grand Rapids. Andrea received her B.S. in pharmacy from Ferris State University in 2001 and Pharm.D. from Midwestern University in 2006. Andrea currently works on the orthopedics/neurology unit at St. Mary's Hospital. Other professional areas of interests include internal medicine and infectious disease/HIV medication therapy. Andrea has been a member of WMSHP since 2001 and is serving as a committee member for MSHP in 2007. Andrea's professional affiliations also include ACCP, MSHP, and ASHP.

    Renee Marana graduated from Ferris State University with her Pharm.D. in 2003. She went on to complete a PGY1 residency at Bronson Methodist Hospital in Kalamazoo, Michigan. Upon completion of her residency, she accepted a decentralized pharmacist position on the General Medical and General Care Units at Bronson, where she continues to practice. In the fall of 2006, she became the residency program director for the Bronson residency program. She has also served on the educational committee and currently serves on the residency committee for the Michigan Society of Health-System Pharmacists.

    Kym Moline works at St Mary's Health Care in Grand Rapids as a clinical pharmacist in the area of Drug Information and Medication Safety. Kym is an adjunct instructor for Ferris and precepts pharmacy externs and residents. She received her B.S and Pharm.D. degrees from Ferris and M.S.A. from Central Michigan University.

    Jackie Morse recently completed a community pharmacy practice residency with Meijer, Pfizer and Ferris State University. She currently holds a shared position as Assistant Professor of Pharmacy Practice with Ferris State University and Disease Management Pharmacist with Meijer Pharmacy in Grandville. Jackie is an active member of ASHP, APhA and currently sits on the Michigan Pharmacists Association's New Practitioner Advisory Committee.

    (Incumbent) Sarah Paulson attended Ferris State University and graduated with her Pharm.D. in 2005. She completed a general pharmacy practice residency at Saint Mary's Health Care in 2006. She is currently a clinical pharmacist at Saint Mary's Health Care assisting in coverage of the inpatient orthopedic unit, neurology unit, and inpatient pharmacy. Sarah has been a member of WMSHP since 2005 and has served as a board member since June 2007. She also has membership with ACCP, ASHP, MPA, MSHP, Phi Lambda Sigma, and Lambda Kappa Sigma.


    (Incumbent) Bill Kriel worked at Spectrum Health Butterworth for 10 years prior to starting at Saint Mary's Health Care 7 years ago. Bill currently compounds chemotherapy medications and NICU TPNs.

    Suzanne Rodgers has been a pharmcacy technician at Borgess Medical Center since February 2005. She graduated in January '05 from Olympia Career Institute with her technician degree. She became a member of WMHSP in '05 and has since attended many CE Dinners. Her outside involvement is with the jail ministry, ministry with community, retention, and nursing home ministry with her local church.

  • October 16, 2007 2:25 PM | Brad Miller (Administrator)

    The American Council for Pharmacy Education (ACPE) recently changed some of their standards, which will effect the way we offer our educational programs. The two changes which effect us most are: 1) continuing education (CE) presentations cannot be given while the participants are eating a meal and 2) presentations should have a different set of questions for pharmacists and technicians. To address the first change, WMSHP's Board will be surveying the membership some time in the next couple months to determine the importance of ACPE-accredited CE (Michigan Board of Pharmacy's CE standards have not changed yet), the importance of offering dinner, and reasonable meeting times. To address the second change, the Board decided to accredit our own CE credits for our technician members. Not only will this solve the issue of separate questions, but it will also save the organization some money, as we currently pay $5 per credit hour of ACPE-accredited CE per person.

    Speaking of technician CE, did you know that any pharmacist can approve continuing education (CE) credits for Certified Pharmacy Technicians (CPhTs)? The Pharmacy Technician Certification Board (PTCB) will allow CPhTs to obtain up to 10 CE credits per licensure period for participating in inservices and other education activities. To obtain credit, a pharmacist must complete PTCB's Universal Continuing Education form, which can be found at their website, www.ptcb.org (click on "CE Credits" under the "CPhT Services" menu).

    It is election season again. WMSHP's board has the following open positions: president-elect, treasurer, board member (4), and technician member. You will be receiving a ballot in the U.S. Mail in the next couple days. Please take the time to fill it out and return it to us. You may return the completed ballot via U.S. Mail, give it to any Board member, or take it to the November meeting. The results will be tallied and announced at the November meeting.

    The November meeting will be held on November 8th at the Food Dance Cafe in Kalamazoo. Dennis Parker, Jr., Pharm.D. from Detroit Receiving Hospital will be giving a presentation on the Management of Intracerebral Hemorrhage. Due to space constraints, the meeting will be limited to the first 40 individuals who RSVP. Please be sure to select your dinner preference when you RSVP.

  • October 01, 2007 2:25 PM | Brad Miller (Administrator)

    Help Wanted: WMSHP is seeking actively engaged members to run for a board position for 2008-2009. Openings include: president-elect, treasurer, board member (4 positions), and technician board member. Experience is not necessary. Mentoring will be provided. If you are interested in running or nominating another member to run, please contact Ryan Bickel at ryanbickel@borgess.com or (269) 226-6616 by October 11th. Elections will be held in late October/early November and the results will be announced at the November meeting.

    Coming Soon: The next WMSHP meeting will be held in Grand Rapids on October 11th at Bar Divani. Dr. David Langholz will discuss hypertension and the role of Tekturna. Continuing education credits will not be offered at this meeting. Please RSVP at www.wmshp.net, if you would like to attend. Seating may be limited, so sign up now.

    Announcement: The MSHP Annual Meeting will be held on Friday, November 2, 2007 at the Lansing Center. This event is open to both MSHP/MPA members and non-members. Students and residents are offered complimentary registration if they register by October 19th. To register, please visit the MPA website, http://www.michiganpharmacists.org, and go to the "Events Calendar" which is found at the "Pharmacy Professionals" link.

  • September 01, 2007 2:26 PM | Brad Miller (Administrator)

    In this month's WMSHP Newsletter, Jeffery Tichenor Pharm.D. writes of the use of recombinant factor VII for massive hemorrhage due to traumatic injury.


    Exsanguination is a leading cause of mortality in severe trauma patients, accounting for approximately 40% of mortality.1 This high incidence of mortality stems from the "lethal triad" of coagulopathy, hypothermia and acidosis associated with massive hemorrhage. Preventing transition to any aspect of the lethal triad is the goal of current treatment. The mainstays of massive hemorrhage management are: ligation, tamponading, or compression of the affected vessels. Other common interventions being: transfusion with fresh frozen plasma, cryoprecipitate, and/or platelet concentrates. The high mortality rate associated with massive hemorrhage bears witness to the fact that current therapeutic options often fall short of their goal in this patient population.

    Recombinant activated factor VII (rFVIIa; Novoseven®) currently has Food and Drug Administration approval for the treatment and prophylaxis of bleeding in patients with Factor VII deficiency, and those with hemophilia with inhibitors to Factors VIII and IX. Factor VII is a vitamin K dependent glycoprotein, structurally similar to human factor VII. Factor VII can exert activity via both the extrinsic and intrinsic pathways in the clotting cascade (see figure below). As predicted by these mechanisms of action, rFVIIa only induces clot formation where vascular injury is present. This ability to form clots only at sites of injury has lead to the investigation of rFVIIa for the management of massive hemorrhage secondary to traumatic injury. Other traits of rFVIIa which make it a potentially attractive agent for use in patients with massive hemorrhage are its short half life of approximately two hours, and its ability to be rapidly infused over 2-5 minutes. rFVIIa has been studied in both penetrating (gunshots and stabbings) and blunt (collisions and attacks) traumas.

    The largest and best carried out of the trials using rFVIIa for the treatment of massive hemorrhage was performed by Boffard and colleagues in 8 countries and 32 hospitals.2 This study included 301 patients with severe trauma. It was a parallel, randomized, placebo controlled, double-blind trial to evaluate the ability of rFVIIa to control bleeding in trauma patients experiencing extensive hemorrhage.2 One arm evaluated the use of rFVIIa in patients with blunt trauma, while the other evaluated its use in patients with penetrating trauma. rFVIIa was administered in consecutive doses of 200, 100, and 100 mcg/kg as deemed necessary by the clinician. The first dose was given after transfusion of the eighth unit of red blood cells (RBCs); and subsequent doses were given after 1 and 3 hours respectively. The blunt trauma arm resulted in RBC transfusions being significantly reduced by 2.6 units (90% CI 0.7 - 4.6, p= 0.02) with rFVIIa compared to placebo.2 The need for massive RBC transfusion, defined as > 20 units of RBC, was also significantly reduced from 33% in patients on placebo to 14% with rFVIIa (p= 0.03).2 Similar trends were noted in the penetrating trauma group, though the results there were not statistically significant.2

    Another well performed trial of rFVIIa for the management of massive hemorrhage was done by Dutton and colleagues. This was a compassionate use study performed on 81 coagulopathic patients.3 The decision to use rFVIIa went through 1 of 2 "gatekeepers" at the facility, dosing was done at 100 mcg/kg. Factor VII restored hemostasis in 75% of the patients (61 of 81), with an average of 1.23 doses.3 Despite this success, mortality at hospital discharge was still approximately 32%.3 This trial also showed that an acidic body pH tempers the effects of rFVIIa. Responders to rFVIIa (n=61) in this study had an average pH of 7.29 while non-responders (n=20) averaged 7.02 (p= 0.0016).3 The research also confirms that patients must have sufficient functional platelet counts at baseline in order for rFVIIa treatment to be effective (patients below 50,000/mcL did not form clots with rFVIIa).3 The researchers compiled a group comparable to their patients as a control (matched on: age, sex, mechanism of injury, abbreviated injury score, laboratory data, clinical outcome, and TRISS probability of survival) and were unable to associate rFVIIa with a long-term survival benefit in their patients.3

    Both of these extensive studies concluded rFVIIa to be beneficial in restoring hemostasis to patients suffering traumatic massive hemorrhage, especially those due to blunt trauma. However, no overall mortality benefit was established with the use of rFVIIa in their patient populations. Though, use of rFVIIa may be beneficial in a select group of trauma patients with massive hemorrhage. Patients with the following characteristics appear to be the best served by rFVIIa therapy.

    - Blunt trauma victim
    - Current treatments exhausted
    - Absence of negative prognosis (sepsis, major organ failure, penetrating head injury)
    - pH >7.1
    - Glasgow Coma Score >8
    - Age >18 & <65 years
    - No history of atherosclerosis or thrombosis


    1. Sauaia A, Moore FA, Moore EE, et. al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38:185-193.
    2. Boffard KD, Riou B, Warren B, et. al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double blind clinical trials. J Trauma 2005;59:8-18.
    3. Dutton RP, McCunn M, Hyder M, et. al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004;57:709-719.
  • September 01, 2007 2:25 PM | Brad Miller (Administrator)

    The summer is drawing to an end. The kids are heading back to school. It is also time for WMSHP to return from its summer break. The next meeting will be held in Kalamazoo on Thursday, September 13th. Check out the website, www.wmshp.net, for more details and to RSVP.

    While we were on our summer recess, ASHP held the House of Delegates meeting. One of the hottest topics at this year's meeting was should residency training be required for new pharmacy graduates to provide direct patient care. After much discussion, they resolved the following:

    To support the position that by the year 2020, the completion of an ASHP-accredited postgraduate-year-one residency should be a requirement for all new college of pharmacy graduates who will be providing direct patient care.

    I am sure that this resolution, as well as, other new professional policies will be discussed at MSHP's annual board retreat this September. I will keep you posted on highlights.

    In addition to our upcoming meeting, I would like to remind you of some other important upcoming dates. First, National Pharmacy Week this year is October 21-27. Information and planning resources can be found at the MPA website, www.michiganpharmacists.org. MSHP's annual meeting is Friday, November 2nd, at the Lansing Center. Registration forms for this meeting will be available at our September and October meetings. Finally, ASHP's 42nd Midyear Clinical Meeting will convene December 2 - 6 in Las Vegas, NV. Reserve your hotel now.

  • April 01, 2007 2:26 PM | Brad Miller (Administrator)

    Now that April is almost upon us, we are starting to see the first signs of spring. For WMSHP, this means that we are also nearing our annual meeting, which highlights some research projects done by Western Michigan pharmacy residents. After a close vote, the Board selected the following two projects to be presented at the April meeting: "Pharmacist Interventions to Improve Adherence Among Patients with HIV/AIDS Starting Antiretroviral Therapy" by Melanie Crain, Pharm.D., and "Evaluation of Microorganisms Responsible for Early versus Late-Onset Hospital-Acquired Pneumonia in Intensive Care Unit Patients" by Sarah-Ann Brown, Pharm.D. I would like to thank all of the area residents for submitting their projects and encourage you to come to the meeting and support Melanie and Sarah-Ann.

    Another spring tradition is the WMSHP Spring Seminar. This year's seminar will be held on Thursday, May 10th, at the Grand Rapids Airport Hilton. It is an excellent opportunity to earn continuing education credits and network with colleagues. Our morning sessions will focus on toxicology and advancing the pharmacy profession, while the afternoon will be broken into two tracks, Administration and Therapeutics. The Administration track will touch upon innovative technician practices, pharmacy law, and the benefits of being a preceptor. Historically, technicians have found the Administration track useful, because it fulfills their law review requirement for certification. The Therapeutics track will provide updates on HIV therapy, women's health, and glycemic control in patients with infections. Reserve the date on your calendars and watch our website, www.wmshp.net, for more information and to register.

  • March 01, 2007 2:27 PM | Brad Miller (Administrator)

    Greetings! I just returned from MPA's Annual Convention and Exposition in Dearborn. It was nice to see many of you out there. I would like to take this opportunity to share with you some highlights from the convention.

    One of the main topics which the MPA focused on this year was getting their membership involved politically to strengthen the profession of pharmacy. They suggested identifying legislators (or potential legislators) in your district that you believe in and supporting them. Support can be as simple as sending them a $10 check to support their campaign or as involved as knocking on doors for them during the campaign season. If you are not comfortable supporting a legislator, please consider supporting MPA's Political Action Coalition (PAC).

    Another highlight of the meeting was finding more preceptors and sites to become involved with training pharmacy students in their P-3 and P-4 years. WMSHP will be working closely with the Michigan Colleges of Pharmacy Experiential Programs (McPEP) group to assist them in identifying preceptors and sites in our region, as well as, supporting their current preceptors and sites. WMSHP has arranged for McPEP to give a presentation at our May 10th Spring Seminar in Grand Rapids. Please mark your calendars for this event.

    Finally, I would like to inform you that Jesse Hogue, Fred Schmidt, and I served as your delegates to the MPA House of Delegates session. During the session, Laura Shaw, Chairman of Michigan's Board of Pharmacy, provided the House with a special report. She reminded us that Michigan's new continuing education (CE) standards (R 338.3041) were recently signed into law. For those of who are not aware of the new standards, starting July 1, 2007, pharmacists will be required to obtain 10 hours of live CE per renewal period, will be required complete one hour of CE in pain management, and will not be permitted to obtain more than 12 hours of CE per day. The new rules can be found at www.michigan.gov/healthlicense under the "Health Professional Administrative Rules" link.

  • February 01, 2007 2:27 PM | Brad Miller (Administrator)

    Wow! We saw record attendance at last month's meeting. Approximately 75 WMSHP members attended the 2006 ICAAC review in Grand Rapids. I want to thank Dana Staat for doing a great job facilitating the unusually large crowd and arranging for Michael Klepser to do the presentation for Michael Tiberg, who encountered a family emergency at the last minute. As a thank you for giving the presentation at such short notice, WMSHP's Board of Directors is extending an honorary lifetime membership to Michael Klepser. Thanks again, Mike!

    One of my responsibilities as your president is to serve as the Regional Delegate to the Michigan Society of Health-System Pharmacists (MSHP). I attended my first MSHP board meeting and committee day on January 18th. It was a great experience meeting pharmacy leaders from around the state and providing them with a summary of our recent activities. I would like to recognize several WMSHP members, who also currently serve on MSHP's Board of Directors: Fred Schmidt, President; Jesse Hogue, Director, and Jean Lee, Director.

    February is going to be a short, but busy month. On February 8th the WMSHP meeting will take place in Kalamazoo. Sandra Chase will be giving a presentation on using low molecular weight heparin in medically ill patients. Also, the MPA's Annual Convention and Exposition (ACE) meeting will take place February 23 -25th in Dearborn. More information regarding the ACE meeting can be found at MPA's website, www.michiganpharmacists.org. I hope to see you at one of the events.

  • January 01, 2007 2:28 PM | Brad Miller (Administrator)

    Happy New Year! Hopefully, you were able to enjoy the holidays with your family and friends.

    I would like to start off the year by introducing this year�s board of directors to you. Your officers include: Ryan Bickel, President; Jesse Hogue, Past President; Dana Staat, President-Elect; Ted Riley, Treasurer; and Brad Miller, Secretary. Your board members include: Jodie Bakus, Bill Kriel, Jean Lee, Kim Melgarejo, Natalie Paul, Shaun Phillips, Cindy Pollock, Jeff Van Houten, and Cheri Woodhams.

    On behalf of the board, I would like to thank Jesse Hogue for all of his hard work and guidance as President. I would also like to recognize Jean Lee for her service as Past-President last year. Fortunately, she will be remaining with us as a board member. Finally, I would like to welcome our newest board member, Cindy Pollock.

    I am honored to serve as your president and look forward to working with you to promote the profession of pharmacy. To assist me in serving you, please feel free to share your ideas regarding educational opportunities, topics of interest, or anything else that pertains to advancing health-system pharmacy.

    Many of you are currently making New Year resolutions. I have a couple ideas that I would like to offer. If you are not currently a member of the Michigan Society of Health-System Pharmacy (MSHP) and Michigan Pharmacists Association (MPA), consider joining. If you are already a member, consider becoming involved with a committee, serving as a delegate, and/or attending the MPA's Annual Convention & Exhibition in February. More information regarding these opportunities can be found at MPA's website, http://www.michiganpharmacists.org.

Powered by Wild Apricot Membership Software